DOI QR코드

DOI QR Code

Relationship Between Obesity and N-Terminal Brain Natriuretic Peptide Level as a Prognostic Value After Acute Myocardial Infarction

  • Choi, Seon-Gyu (Department of Internal Medicine, Yeosu Chonnam Hospital) ;
  • Jeong, Myung-Ho (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) ;
  • Ahn, Young-Keun (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) ;
  • Cho, Jeong-Gwan (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) ;
  • Kang, Jung-Chaee (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) ;
  • Chae, Shung-Chull (Department of Internal Medicine, Kyungpook National University College of Medicine) ;
  • Hur, Seung-Ho (Department of Internal Medicine, Keimyung University College of Medicine) ;
  • Hong, Taek-Jong (Department of Internal Medicine, Pusan National University Schoool of Medicine) ;
  • Kim, Young-Jo (Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Seong, In-Whan (Department of Internal Medicine, Chungnam National University College of Medicine) ;
  • Chae, Jei-Keon (Department of Internal Medicine, Chonbuk National University College of Medicine) ;
  • Rhew, Jay-Young (Department of Internal Medicine, Jeonju Presbyterian Medical Center) ;
  • Chae, In-Ho (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Cho, Myeong-Chan (Department of Internal Medicine, Chungbuk National College of Medicine) ;
  • Bae, Jang-Ho (Department of Internal Medicine, Konyang University College of Medicine) ;
  • Rha, Seung-Woon (Department of Internal Medicine, Korea University College of Medicine) ;
  • Kim, Chong-Jin (Department of Internal Medicine, Kyunghee University College of Medicine) ;
  • Choi, Dong-Hoon (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Jang, Yang-Soo (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Yoon, Jung-Han (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Chung, Wook-Sung (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Seung, Ki-Bae (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Park, Seung-Jung (Department of Internal Medicine, University of Ulsan College of Medicine)
  • Received : 2010.01.22
  • Accepted : 2010.04.13
  • Published : 2010.11.30

Abstract

Background and Objectives: Recently, the prognostic value of N-terminal brain natriuretic peptide (NT-proBNP) in acute coronary syndrome has been demonstrated in many studies. However, NT-proBNP levels are influenced by various factors such as sex, age, renal function, heart failure severity, and obesity. NT-proBNP concentrations tend to decrease with higher body mass index (BMI). The aim of this study was to examine the influence of obesity on NT-proBNP as a predictive prognostic factor in acute myocardial infarction (AMI) patients. Subjects and Methods: Using data from the Korea Acute Myocardial Infarction Registry (January 2005 to September 2008), 2,736 AMI patients were included in this study. These patients were divided into men (n=1,972, 70%) and women (n=764, 30%), and were grouped according to their BMIs. Major adverse cardiac events (MACE) during 1 year clinical follow-up were evaluated. Results: NT-proBNP was significantly higher in lower BMI (p<0.001). Mean NT-proBNP levels of each obesity group were 2,393${\pm}$4,022 pg/mL in the lean group (n=875), 1,506${\pm}$3,074 pg/mL in the overweight group (n=724) and 1,100${\pm}$1,137 pg/mL in the obese group (n=1,137) (p<0.01). NT-proBNP was an independent prognostic factor of AMI in obese patients by multivariative analysis of independent risk factors of MACE (p=0.01). Conclusion: NT-proBNP is lower in obese AMI patients than in non-obese AMI patients, but NT-proBNP is still of independent prognostic value in obese AMI patients.

Keywords

References

  1. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003;163:2345-53. https://doi.org/10.1001/archinte.163.19.2345
  2. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835-42. https://doi.org/10.1001/jama.284.7.835
  3. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9. https://doi.org/10.1161/01.CIR.97.19.1921
  4. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003;108:275-81. https://doi.org/10.1161/01.CIR.0000079170.10579.DC
  5. Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006;47:742-8. https://doi.org/10.1016/j.jacc.2005.11.030
  6. Goetze JP, Christoffersen C, Perko M, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;17:1105-7. https://doi.org/10.1096/fj.02-0796fje
  7. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21. https://doi.org/10.1056/NEJMoa011053
  8. Raymond I, Groenning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745-51. https://doi.org/10.1136/heart.89.7.745
  9. Anwaruddin S, Lloyd-Jones DM, Baggish A, et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006;47:91-7. https://doi.org/10.1016/j.jacc.2005.08.051
  10. Das SR, Drazner MH, Dries DL, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005;112:2163-8. https://doi.org/10.1161/CIRCULATIONAHA.105.555573
  11. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004;43:1590-5. https://doi.org/10.1016/j.jacc.2003.10.066
  12. Lee KH, Jeong MH, Ahn YK, et al. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008;130:227-34. https://doi.org/10.1016/j.ijcard.2007.08.044
  13. Low S, Chin MC, Ma S, Heng D, Durenberg-Yap M. Rationale for redefining obesity in Asians. Ann Acad Med Singapore 2009;38:66-9.
  14. Kim SH, Kim JS, Baek KK, et al. Role of NT-proBNP in evaluation of functional status in congestive heart failure. Korean Circ J 2004;34:894-9.
  15. Baek KK, Jeon ES, Rhee I, et al. N-terminal pro-B-type natriuretic peptide as a prognostic marker in acute coronary syndrome. Korean Circ J 2004;34:1070-81. https://doi.org/10.4070/kcj.2004.34.11.1070
  16. Kim KS, Han HS, Hwang KK, Youn TJ, Kim DW, Cho MC. The plasma level of N-terminal pro B-type natriuretic peptide (NT-proBNP) for severity of coronary artery stenosis and early risk stratification in patients with non-ST elevation acute coronary syndrome. Korean Circ J 2004;34:133-41. https://doi.org/10.4070/kcj.2004.34.2.133
  17. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45. https://doi.org/10.1016/S0735-1097(02)01986-1
  18. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-22. https://doi.org/10.1016/S0140-6736(03)13976-1
  19. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967;20:457-64. https://doi.org/10.1016/0002-9149(67)90023-9
  20. Wang TJ, Larson MG, Levy D, et al, Impact of obesity on natriuretic peptide levels. Circulation 2004;109:594-600. https://doi.org/10.1161/01.CIR.0000112582.16683.EA
  21. McCord J, Mundy BJ, Hudson MP, et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 2004;164:2247-52. https://doi.org/10.1001/archinte.164.20.2247
  22. Tosa S, Watanabe H, Iino K. Usefulness of plasma BNP levels as a marker of left ventricular wall stress in obese individuals. Int Heart J 2009;50:173-82. https://doi.org/10.1536/ihj.50.173
  23. Licata G, Volpe M, Scaglione R, Rubattu S. Salt-regulating hormones in young normotensive obese subjects: effects of saline load. Hypertension 1994;23(1 Suppl):I20-4. https://doi.org/10.1161/01.HYP.23.1_Suppl.I20
  24. Morabito D, Vallotton MB, Lang U. Obesity is associated with impaired ventricular protein kinase C-MAP kinase signaling and altered ANP mRNA expression in the heart of adult Zucker rats. J Investig Med 2001;49:310-8 https://doi.org/10.2310/6650.2001.33895
  25. Choe HM, Yoo BS, Ryu HY, et al. The early changing pattern of the B-type natriuretic peptide concentration and its significance as a prognostic marker after acute myocardial infarction. Korean Circ J 2006;36:526-34.

Cited by

  1. The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study vol.15, pp.None, 2010, https://doi.org/10.1186/s12933-016-0370-0